CHTOP and ovarian cancer: In summary, our results reveal that the overexpression of CHTOP is associated with an enhanced phenotype of metastasis, chemoresistance, and stemness in epithelial ovarian cancer cells, while CHTOP inhibition can abolish the malignant behaviors of epithelial ovarian cancer cells, which makes it possible to improve current ovarian cancer treatment by targeting CHTOP.